Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. [electronic resource]
Producer: 20111108Description: 2564-78 p. digitalISSN:- 1531-5053
- Actins -- metabolism
- Apoptosis
- Becaplermin
- Bone Density Conservation Agents -- adverse effects
- Caspase 3 -- metabolism
- Cell Adhesion -- drug effects
- Cell Culture Techniques
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Diphosphonates -- adverse effects
- Diterpenes -- pharmacology
- Fibroblasts -- drug effects
- Gingiva -- cytology
- Humans
- Imidazoles -- adverse effects
- In Situ Nick-End Labeling
- Pamidronate
- Platelet-Derived Growth Factor -- pharmacology
- Proto-Oncogene Proteins c-sis
- Recombinant Proteins -- pharmacology
- Wound Healing -- drug effects
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.